Chobanian AV, Bakris GL, Black HR, et al
By focusing on adherence, dosing, lifestyle, and individualized care, clinicians can often improve outcomes
This isnt a quick fix
Its a moment of mindful self-care that takes just a few minutes, usually before I settle down with my Nintendo Switch
Regulatory Timeline (According to FDA Announcements): October 2, 2024: FDA indicated tirzepatide shortage resolved (later superseded) December 19, 2024: FDA issued a declaratory order reaffirming shortage resolution February 18, 2025: 503A enforcement discretion ended March 19, 2025: 503B enforcement discretion ended Industry Context: Some reporting has described ongoing disputes about how certain compounded tirzepatide formulations are marketed following shortage-related enforcement discretion changes
Sumimoto R, Hirai T, Fujita M, Murakami H, Otake Y, Huang C-L